Clinical Trial Update: Anti-Leukemia Immune Responses After Irradiation of Extramedullary Tumors [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial is exploring anti-leukemia immune responses after irradiation of extramedullary tumors in patients with acute myeloid leukemia; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Myeloid Leukemia, Myeloid Leukemia | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING